Abstract:Mendelian randomization (MR) is an approach to causal inference that utilises genetic variants to obtain estimates of the causal effect of an exposure on an outcome in the presence of unobserved confounding. MR relies on a set of assumptions to obtain unbiased effect estimates, one of these assumptions is that there is no pathway from the genetic variants to the outcome that does not act through the exposure. Increasing genome-wide association study (GWAS) sample sizes for the exposure enables discovery of instrumental variables with smaller effect sizes. We illustrate through simulations how smaller effect sizes could arise from genetic variants that act through traits that have greater liability to confound an exposure-outcome relationship. When such genetic variants are selected as instruments this can bias the MR effect estimate obtained from that instrument in the same direction as the confounded observational association but with larger magnitude. Through simulation we illustrate how the total bias of the MR estimates increases across a range of standard MR estimation methods increases as the proportion of the genetic instruments that are associated with the confounder increases. However, if such heritable confounders are known and can be instrumented, the confounder free effect estimate can be obtained through applying a pre-estimation filtering to standard MR methods, removing instruments that explain more variation in that confounder than the exposure, or by estimating effects through multivariable MR. We highlight the potential for SNPs identified in GWAS to be associated with potential confounders through examination of a recent GWAS of C-Reactive Protein. Finally, we illustrate our approach through estimation of the causal effect of age at menarche on type 2 diabetes, hypothesising that the MR effect estimate may be biased by confounding due to the inclusion of genetic variants associated with early life adiposity as instruments.

Inference of causal and pleiotropic effects with multiple weak genetic instruments: application to effect of adiponectin on type 2 diabetes

Powerful genome-wide design and robust statistical inference in two-sample summary-data Mendelian randomization

Bias from heritable confounding in Mendelian randomization studies

Conditional inference in cis-Mendelian randomization using weak genetic factors

Distinct metabolic features of genetic liability to type 2 diabetes and coronary artery disease: a reverse Mendelian randomization study

Mendelian randomization with fine-mapped genetic data: Choosing from large numbers of correlated instrumental variables

Insights from Two-Sample and Multivariable Mendelian Randomization

Robust instrumental variable methods using multiple candidate instruments with application to Mendelian randomization

Robust use of phenotypic heterogeneity at drug target genes for mechanistic insights: Application of cis‐multivariable Mendelian randomization to GLP1R gene region

Re: "Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects".

An efficient and robust approach to Mendelian randomization with measured pleiotropic effects in a high-dimensional setting

Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator

Selecting invalid instruments to improve Mendelian randomization with two-sample summary data

Inference After Selecting Plausibly Valid Instruments with Application to Mendelian Randomization

MR-link-2: pleiotropy robust Mendelian randomization validated in four independent gold-standard datasets of causality

Exploring and accounting for genetically driven effect heterogeneity in Mendelian Randomization

Causal inference for multiple risk factors and diseases from genomics data

Inferring the Direction of a Causal Link and Estimating Its Effect via a Bayesian Mendelian Randomization Approach

A latent outcome variable approach for Mendelian randomization using the expectation maximization algorithm

MR-link-2: pleiotropy robust cis Mendelian randomization validated in four independent gold-standard datasets of causality

A Novel One‐Sample Mendelian Randomization Approach for Count‐Type Outcomes That Is Robust to Correlated and Uncorrelated Pleiotropic Effects